GHK
Copper Tripeptide-1 — a naturally occurring copper-binding peptide studied for collagen synthesis, skin repair, antioxidant activity, and connective-tissue remodeling.
GHK (Glycine-Histidine-Lysine Copper) is a naturally occurring tripeptide that binds copper ions and is found in human plasma, saliva, and urine. First isolated in 1973, it has since been extensively studied for its role in wound healing, skin regeneration, and connective-tissue maintenance.
The mechanism centers on copper’s role as an essential cofactor in collagen and elastin cross-linking, combined with the peptide’s ability to upregulate gene expression related to tissue repair, antioxidant defense, and anti-inflammatory pathways. Research suggests GHK can activate over 4,000 genes involved in tissue repair and regeneration.
GHK has one of the more robust evidence bases among commonly researched repair peptides, particularly for topical applications. Subcutaneous use is physician-practice based. It is not WADA-prohibited and is widely used in both cosmetic and research contexts.
What are you researching?
Tell us your focus area and we’ll send a personalized research guide covering relevant compounds, pairings, and sourcing.
GHK is not prohibited by WADA. Topical applications have a well-established safety profile from decades of cosmetic use. Subcutaneous use carries no established long-term safety data at higher doses. Prolonged high-dose copper exposure may present accumulation risks — physician-practice protocols flag this.
All information on this page is for educational reference only and does not constitute medical advice.